Humira Biosimilar Market

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,500	155 Pages	Coherent Market Insights	June, 2023	CMI18107569

Best Price Guarantee
Price	from $4,500
Length	155 Pages
Publisher	Coherent Market Insights
Published Date	June, 2023
SKU	CMI18107569

Humira Biosimilar Market, By Product Type (Biosimilar Humira (Adalimumab), Interchangeable Biosimilar Humira), By Indication (Rheumatoid Arthritis, Psoriasis, Crohn\'s Disease, Ulcerative Colitis, Ankylosing Spondylitis, Juvenile Idiopathic Arthritis, Other Autoimmune Conditions), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Patient Age (Adult Patients, Pediatric Patients), By Application (Rheumatology, Dermatology, Gastroenterology, Other Therapeutic Areas), By Administration (Subcutaneous (SC) Injection, Intravenous (IV) Infusion), By Dosage Strength (40 mg/0.8 mL, Other dosage strengths), By End-User (Hospitals, Specialty Clinics, Others), By Packaging Type (Pre-filled Syringes, Autoinjectors, Vials), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030

Humira, a biologic medication used to treat autoimmune conditions like psoriasis and rheumatoid arthritis, is the most popular biologic medication in the world. Following the expiration of patent protection for Humira in some regions, biosimilars—which are highly similar copies of biologic medications in terms of safety, efficacy, and quality—have hit the market. These biosimilars encourage competition and may result in price reductions. They help lower costs and improve patient access to essential pharmaceuticals by offering more economical treatment options.

Market Dynamics

Patent expiration, cost savings, increasing prevalence of autoimmune diseases, favorable regulatory environment are major factors expected to drive growth of the global cerebral angiography market during the forecast period.

For instance, the market for multiple Humira biosimilars has been approved and introduced in Europe, which has been in the forefront of the acceptance of biosimilars. Due to the region's existing legal framework and policies supporting biosimilar adoption, there will likely be more market competition and potential cost reductions.

However, complex regulatory processes, intellectual property and patent litigation, and physician and patient awareness are expected to hamper growth of the global cerebral angiography market over the forecast period.

Key features of the study:

This report provides in-depth analysis of the global humira biosimilar market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023–2030), considering 2022 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global humira biosimilar market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Amgen Inc., Samsung Bioepis Co., Ltd., Sandoz International GmbH (Novartis AG), Mylan N.V., Boehringer Ingelheim International GmbH, Pfizer Inc., Fresenius Kabi AG, Coherus BioSciences, Inc., Biogen Inc., AbbVie Inc., Celltrion Inc., Amneal Pharmaceuticals, Inc., Lupin Pharmaceuticals, Inc., Merck & Co., Inc., Viatris Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global humira biosimilar market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global humira biosimilar market

Detailed Segmentation:

Global Humira Biosimilar Market, By Product Type:
Biosimilar Humira (Adalimumab)
Interchangeable Biosimilar Humira
Global Humira Biosimilar Market, By Indication:
Rheumatoid Arthritis
Psoriasis
Crohn's Disease
Ulcerative Colitis
Ankylosing Spondylitis
Juvenile Idiopathic Arthritis
Other Autoimmune Conditions
Global Humira Biosimilar Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Humira Biosimilar Market, By Patient Age:
Adult Patients
Pediatric Patients
Global Humira Biosimilar Market, By Application:
Rheumatology
Dermatology
Gastroenterology
Other Therapeutic Areas
Global Humira Biosimilar Market, By Administration:
Subcutaneous (SC) Injection
Intravenous (IV) Infusion
Global Humira Biosimilar Market, By Dosage Strength:
40 mg/0.8 mL
Other dosage strengths
Global Humira Biosimilar Market, By End User:
Hospitals
Specialty Clinics
Others
Global Humira Biosimilar Market, By Packaging Type:
Pre-filled Syringes
Autoinjectors
Vials
Global Humira Biosimilar Market, By Region:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles
Amgen Inc.
Samsung Bioepis Co., Ltd.
Sandoz International GmbH (Novartis AG)
Mylan N.V.
Boehringer Ingelheim International GmbH
Pfizer Inc.
Fresenius Kabi AG
Coherus BioSciences, Inc.
Biogen Inc.
AbbVie Inc.
Celltrion Inc.
Amneal Pharmaceuticals, Inc.
Lupin Pharmaceuticals, Inc.
Merck & Co., Inc.
Viatris Inc.

1. Research Objectives and Assumptions: Research Objectives; Assumptions; Abbreviations
2. Market Purview: Report Description; Market Definition and Scope; Executive Summary; Market Snapshot, By Product Type; Market Snapshot, By Indication; Market Snapshot, By Distribution Channel; Market Snapshot, By Patient Age; Market Snapshot, By Application; Market Snapshot, By Administration; Market Snapshot, By Dosage Strength; Market Snapshot, By End User; Market Snapshot, By Packaging Type; Market Snapshot, By Region; Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis: Market Dynamics; Increasing prevalence of autoimmune diseases; Complex Regulatory Processes; Enhanced treatment choices and global market expansion; Impact Analysis; Key Highlights; Regulatory Scenario; Product launch/Approvals; PEST Analysis; PORTER’s Analysis; Merger and Acquisition Scenario
4. Global Humira Biosimilar Market – Impact of Coronavirus (COVID-19) Pandemic: COVID-19 Epidemiology; Supply Side and Demand Side Analysis; Economic Impact
5. Global Humira Biosimilar Market , By Product Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Biosimilar Humira (Adalimumab); Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn); Interchangeable Biosimilar Humira; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Mn)
6. Global Humira Biosimilar Market , By Indication, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Rheumatoid Arthritis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Psoriasis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Crohn’s disease; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Ulcerative Colitis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Ankylosing Spondylitis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Juvenile Idiopathic Arthritis; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Other Autoimmune Conditions; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
7. Global Humira Biosimilar Market , By Distribution Channel, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospital Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Retail Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Online Pharmacies; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
8. Global Humira Biosimilar Market , By Patient Age, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Adult Patients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Pediatric Patients; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
9. Global Humira Biosimilar Market , By Application, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Rheumatology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Dermatology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Gastroenterology; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Other Therapeutic Areas; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
10. Global Humira Biosimilar Market , By Administration, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Subcutaneous (SC) Injection; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Intravenous (IV) Infusion; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
11. Global Humira Biosimilar Market , By Dosage Strength, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends
40 mg/0.8 mL: Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Other dosage strengths; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
12. Global Humira Biosimilar Market , By End User, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Hospitals; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Specialty Clinics; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Others; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
13. Global Humira Biosimilar Market , By Packaging Type, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, 2023 and 2030 (%); Y-o-Y Growth Analysis, 2018 – 2030; Segment Trends; Pre-filled Syringes; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Autoinjectors; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million); Vials; Introduction; Market Size and Forecast, and Y-o-Y Growth, 2023-2030,(US$ Million)
14. Global Humira Biosimilar Market , By Region, 2023-2030, (US$ Mn): Introduction; Market Share Analysis, By Country, 2023 and 2030 (%); Y-o-Y Growth Analysis, For Country 2018 –2030; Country Trends; North America; Introduction; Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Indication, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Region, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Application, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Administration, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Dosage Strength, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By End User, 2023-2030,(US$ Mn); Market Size and Forecast, and Y-o-Y Growth, By Packaging Type, 2023-2030,(US$ Mn); Europe; Asia Pacific; Latin America; Middle East & Africa
15. Competitive Landscape: Amgen Inc.; Company Highlights; Product Portfolio; Key Developments; Financial Performance; Strategies; Samsung Bioepis Co.; Sandoz International GmbH (Novartis AG); Mylan N.V.; Boehringer Ingelheim International GmbH; Pfizer Inc.; Fresenius Kabi AG; Coherus BioSciences; Biogen Inc; AbbVie Inc; Celltrion Inc; Amneal Pharmaceuticals; Lupin Pharmaceuticals; Merck & Co; Viatris Inc.; Analyst Views
16. Section: Research Methodology; About us; *Browse 24 market data tables and 28 figures on “Global Humira Biosimilar Market” - Global forecast to 2030